ENLIVEN THERAPEUTICS, INC. (ELVN) Operating income 2019–2025
ENLIVEN THERAPEUTICS, INC. (ELVN) annual operating income history from SEC filings — each fiscal year as reported.
-$119.7MFY2025 · since FY2019: -$24.1M → -$119.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$119.7M | -14.4% |
| FY2024 | -$104.6M | -25.2% |
| FY2023 | -$83.5M | -115.3% |
| FY2022 | -$38.8M | +24.6% |
| FY2021 | -$51.4M | -23.4% |
| FY2020 | -$41.7M | -72.9% |
| FY2019 | -$24.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ELVN financial trends
ELVN RevenueELVN Net incomeELVN Net marginELVN Gross profitELVN Gross marginELVN Operating marginELVN Operating cash flowELVN Free cash flowELVN Capital expendituresELVN Return on equityELVN Stock buybacksELVN Dividends paidELVN Total assetsELVN Total liabilitiesELVN Shareholders’ equityELVN overview →